Yuandong Biology: Shareholders intend to transfer 3.3695 million shares at a price to be inquired, accounting for 1.91% of the total share capital of the company.

Yuandong Bio announced that Chengdu Nanyuan Investment Partnership Enterprise, Chengdu Zhuyuan Investment Partnership Enterprise, and Chengdu Juyuan Investment Partnership Enterprise plan to participate in the company's pre-IPO shareholder inquiry transfer. The total number of shares to be transferred is 3.3695 million, accounting for 1.91% of the total share capital of the company. This inquiry transfer is a non-public transfer, and the transferee shall not transfer the shares acquired through the inquiry transfer within 6 months after the transfer. The transferee must be an institutional investor with the corresponding pricing ability and risk-bearing capacity. The reason for the transfer is the need for their own funds, and the minimum price shall not be lower than 70% of the average stock trading price in the 20 trading days before the date of sending the subscription invitation letter.